TP53 and cancer: Jennis et al. [47] reported that a prevalent single nucleotide polymorphism (SNP) in p53 detected in individuals of African descent is related to increased cancer incidence in mouse models, and cells carrying this mutation resist ferroptosis through modifying glutamine metabolism.